726
Views
0
CrossRef citations to date
0
Altmetric
Hematology

Comparison of anti-thymocyte globulin-based immunosuppressive therapy and allogeneic hematopoietic stem cell transplantation in patients with transfusion-dependent non-severe aplastic anaemia: a retrospective study from a single centre

, , , , , , , , , , , , , , , , , , & ORCID Icon show all
Article: 2271475 | Received 16 May 2023, Accepted 11 Oct 2023, Published online: 23 Oct 2023

References

  • Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood. 2006;108(8):1–12. doi: 10.1182/blood-2006-03-010777.
  • Nishio N, Yagasaki H, Takahashi Y, et al. Natural history of transfusion-independent non-severe aplastic anemia in children. Int J Hematol. 2009;89(4):409–413. doi: 10.1007/s12185-009-0302-9.
  • Killick SB, Bown N, Cavenagh J, et al. Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol. 2016;172(2):187–207. doi: 10.1111/bjh.13853.
  • Red Blood Cell Disease Group CSoHCMA. [Chinese expert consensus on the diagnosis and treatment of aplastic anemia (2017.)]Zhonghua Xue Ye Xue Za Zhi. 2017;38(1):1–5. doi: 10.3760/cma.j.issn.0253-2727.2017.01.001.
  • Song L, Peng GX, Wu ZJ, et al. [Treatment of transfusion-dependent nonsevere aplastic anemia with cyclosporine a plus ATG/ALG versus cyclosporine a plus androgens: a retrospective single center study]. Zhonghua Xue Ye Xue Za Zhi. 2016;37(11):946–951. doi: 10.3760/cma.j.issn.0253-2727.2016.11.004.
  • Ahn MJ, Choi JH, Lee YY, et al. Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation: multicenter trial. Int J Hematol. 2003;78(2):133–138. doi: 10.1007/BF02983381.
  • Zhang M, Zhu G, Cai L, et al. Efficacy of hematopoietic stem cell transplantation in the treatment of children with non-severe aplastic anemia. Pediatr Transplant. 2022;26(7):e14340. doi: 10.1111/petr.14340.
  • Camitta BM, Thomas ED. Severe aplastic anaemia: a prospective study of the effect of androgens or transplantation on haematological recovery and survival. Clin Haematol. 1978;7(3):587–595.
  • Sureda A, Bader P, Cesaro S, et al. Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015. Bone Marrow Transplant. 2015;50(8):1037–1056. doi: 10.1038/bmt.2015.6.
  • Olsson R, Remberger M, Schaffer M, et al. Graft failure in the modern era of allogeneic hematopoietic SCT. Bone Marrow Transplant. 2013;48(4):537–543. doi: 10.1038/bmt.2012.239.
  • Lin F, Zuo Y, Zhang Y, et al. The impact of pretransplant serum ferritin on haploidentical hematopoietic stem cell transplant for acquired severe aplastic anemia in children and adolescents. Pediatr Blood Cancer. 2022;69(9):e29845. doi: 10.1002/pbc.29845.
  • Harris AC, Young R, Devine S, et al. International, multicenter standardization of acute graft-versus-Host disease clinical data collection: a report from the mount sinai acute GVHD international consortium. Biol Blood Marrow Transplant. 2016;22(1):4–10. doi: 10.1016/j.bbmt.2015.09.001.
  • Filipovich AH, Weisdorf D, Pavletic S, et al. National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: i. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11(12):945–956. doi: 10.1016/j.bbmt.2005.09.004.
  • Song L, Zhao X, Peng GX[, et al. Retrospective single center study comparing the combination of cyclosporine and antithymocyte globulin and the combination of cyclosporine and androgens for treatment of patients with transfusion-dependent nonsevere aplastic anemia. ]. Journal of Clinical Hematology. 2019;32(05):358–362 + 66. doi: 10.13201/j.issn.1004-2806.2019.05.008.
  • Drexler B, Zurbriggen F, Diesch T, et al. Very long-term follow-up of aplastic anemia treated with immunosuppressive therapy or allogeneic hematopoietic cell transplantation. Ann Hematol. 2020;99(11):2529–2538. doi: 10.1007/s00277-020-04271-4.
  • Xu ZL, Zhou M, Jia JS, et al. Immunosuppressive therapy versus haploidentical transplantation in adults with acquired severe aplastic anemia. Bone Marrow Transplant. 2019;54(8):1319–1326. doi: 10.1038/s41409-018-0410-3.
  • Alessandrino EP, Della Porta MG, Bacigalupo A, et al. Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study. Haematologica. 2010;95(3):476–484. doi: 10.3324/haematol.2009.011429.
  • Taoka K, Kumano K, Nakamura F, et al. The effect of iron overload and chelation on erythroid differentiation. Int J Hematol. 2012;95(2):149–159. doi: 10.1007/s12185-011-0988-3.
  • Ye L, Jing L, Peng G, et al. [Effects of pre-immunosupressive therapy iron overload on hematologic response of severe aplastic anemia]. Zhonghua Xue Ye Xue Za Zhi. 2016;37(4):324–328. doi: 10.3760/cma.j.issn.0253-2727.2016.04.015.
  • Maciejewski JP, Selleri C. Evolution of clonal cytogenetic abnormalities in aplastic anemia. Leuk Lymphoma. 2004;45(3):433–440. doi: 10.1080/10428190310001602363.
  • Kim SY, Lee JW, Lee SE, et al. The characteristics and clinical outcome of adult patients with aplastic anemia and abnormal cytogenetics at diagnosis. Genes Chromosomes Cancer. 2010;49(9):844–850. doi: 10.1002/gcc.20793.
  • Dijiong W, Xiaowen W, Linlong X, et al. Iron chelation effect of curcumin and baicalein on aplastic anemia mouse model with iron overload. Iran J Basic Med Sci. 2019;22(6):660–668. doi: 10.22038/ijbms.2019.30840.7440.
  • Bullen JJ, Rogers HJ, Spalding PB, et al. Natural resistance, iron and infection: a challenge for clinical medicine. J Med Microbiol. 2006;55(Pt 3):251–258. doi: 10.1099/jmm.0.46386-0.